Waters forecasts first-quarter profit below Wall Street estimates, shares slide

Reuters
Feb 09
Waters forecasts first-quarter profit below Wall Street estimates, shares slide

Feb 9 (Reuters) - Waters WAT.N said on Monday it expects first-quarter profit to fall below Wall Street estimates, sending shares of the lab equipment maker down nearly 12% in premarket trading as investors weighed the outlook and a revenue decline at the Becton Dickinson unit it acquired last year.

The company, however, forecast better-than-expected full-year profit, reflecting contributions from its $17.5 billion buyout of Becton Dickinson's bioscience and diagnostics business, which it bought to broaden its reach in clinical and diagnostic applications.

Separately, Becton posted an 8.3% year-over-year decline in revenue from its life sciences segment, which includes biosciences and diagnostic solutions, for the quarter ended December 31. The business posted sales of $766 million.

"Overall, it looks like the BD revenue came in lighter than expected, so it may be a heavier lift to improve operations in that business... than previously expected," Morningstar analyst Julie Utterback said.

Waters forecast first-quarter profit of $2.25 to $2.35 per share, versus analysts' average estimate of $2.51, according to LSEG data.

For 2026, Waters said it expects 5.3% combined company sales growth at the midpoint, including the benefit from the acquisition.

It projected 2026 adjusted profit of $14.30 to $14.50 per share, above analysts' average estimate of $14.32.

Waters expects full-year organic revenue of $3.35 billion to $3.40 billion, compared with estimates of $3.36 billion, and said the acquired Becton Dickinson business should add about $3 billion to reported 2026 revenue.

The unit brought in sales of $766 million in the quarter, below analysts' estimate of $1.3 billion.

Waters supplies lab equipment and technology globally, with most revenue coming from biopharma customers that use its tools for research and drug development.

The company reported fourth-quarter adjusted profit of $4.53 per share, topping estimates of $4.51, while revenue rose about 7% to $932 million, compared with expectations of $928.1 million.

(Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Tasim Zahid)

((Gnaneshwar.Rajan@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10